Why Pelvic Floor Rehabilitation Is Key For Bladder Cancer Patients
Cancer treatment has improved significantly over the past several decades, meaning that more people are living longer after undergoing surgical and medical interventions. This has led to the emergence of an area of cancer care called survivorship, which takes a holistic view of the patient’s well-being and sometimes involves therapies that haven’t always been part of the oncology playbook. In the case of bladder cancer, survivorship and improving quality of life post-surgery sometimes means physical therapy that focuses on improving the function of the pelvic floor. The pelvic floor refers to “the muscles...
Source: TIME: Health - August 10, 2022 Category: Consumer Health News Authors: Elaine K. Howley Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news

Camp Lejeune Veterans Win Justice
On Wednesday, Aug. 10, President Joe Biden signed the comprehensive Honoring Our PACT Act of 2022 into law, allowing military veterans and families harmed by contaminated water at Marine Corps Base Camp Lejeune to file lawsuits against the federal government. The Camp Lejeune Justice Act of 2022, which focuses on four decades of water contamination, is just one part of the much broader PACT Act, which expands access to health care and disability benefits for veterans harmed by toxic exposures around the world. Biden lauded the bipartisan support for the PACT Act at the signing. “There are a lot of issues we can...
Source: Asbestos and Mesothelioma News - August 10, 2022 Category: Environmental Health Authors: Chris Elkins Tags: Veterans Source Type: news

Episode 3: How Can ctDNA Testing Improve Bladder Cancer Care? Episode 3: How Can ctDNA Testing Improve Bladder Cancer Care?
Drs Cheryl Lee and Peter Black share exciting new ways to use liquid biopsy ctDNA testing for bladder cancer diagnostics and patient monitoring.Medscape (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - August 10, 2022 Category: Pathology Tags: Urology InDiscussion Source Type: news

Bladder cancer: New drug approved by regulator which could transform patient’s lives
CANCER in all its forms is a pernicious and deadly disease. However, it is a fight scientists are slowly winning with new drugs designed to get around cancer's grasp. (Source: Daily Express - Health)
Source: Daily Express - Health - July 31, 2022 Category: Consumer Health News Source Type: news

Bladder cancer patients who are too frail for chemo offered hope as health chiefs approve drug
In a milestone ruling, UK health chiefs have approved nivolumab for sufferers who are too frail to withstand treatments such as chemotherapy (file photo) (Source: the Mail online | Health)
Source: the Mail online | Health - July 30, 2022 Category: Consumer Health News Source Type: news

How to Return to Normal After Having Your Bladder Surgically Removed
When Jodi Byfuglin, 56, was diagnosed with bladder cancer, it felt like cruel irony. Byfuglin had lost both her parents to cancer in their 50s, and as a single mother of two, she was all her kids had left. “I promised that I would not leave them,” Byfuglin says. Bladder cancer is the sixth most common cancer in the United States, and older men are at highest risk. But about one-tenth of cases are in people younger than 55, and an estimated 19,480 women will be diagnosed with bladder cancer in 2022 (compared to about 61,700 men), according to the American Cancer Society. “I had no idea about bladder cancer...
Source: TIME: Health - July 28, 2022 Category: Consumer Health News Authors: Simar Bajaj Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news

WHO Reclassifies Firefighting as High-Risk Occupation for Cancer
The World Health Organization has reclassified firefighting to its highest level of occupational risk for cancer after extensive research confirmed an alarming level of malignant mesothelioma incidence. The International Agency for Research on Cancer, which is part of WHO, found that firefighters had a 58% higher risk than the general population of developing mesothelioma, a rare cancer caused by exposure to asbestos fibers. These findings led to the occupation being reclassified recently as “carcinogenic to humans,” earning it Group 1 status for cancer risk and confirming what many already believed. “This r...
Source: Asbestos and Mesothelioma News - July 28, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos Exposure Mesothelioma Source Type: news

The Latest Breakthroughs That Could Help Bladder Cancer Patients
Toward the end of the 19th century, a New York City surgeon named Dr. William Coley purposely injected one of his patients with streptococcal bacteria. Coley wasn’t crazy. He hoped the bacterial infection would stimulate an immune response that would slow the spread of his patient’s cancer, which was inoperable. The experiment worked; the patient’s tumor shrank. For the next 40 years, Coley and his research collaborators would test similar remedies on more than 1,000 cancer patients. They had failures but also many successes, especially among people with bone or soft-tissue cancers. Today, Coley is someti...
Source: TIME: Health - July 27, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news

Firefighting a Carcinogenic Occupation, Warn Experts Firefighting a Carcinogenic Occupation, Warn Experts
Firefighters have occupational exposure that meets five of the 10 criteria for being carcinogenic and is directly related to increased rates of mesothelioma and bladder cancer, say international experts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 22, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022
Basel, 21 July 2022Group sales up 5%1 at constant exchange rates (CER) and 5% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for new medicines to treat severe diseases; as expected, the impact of biosimilars slows down furtherDiagnostics Divisionsales grow 11%; ongoing strong base business; demand for COVID-19 tests is expected to decline in the second half of the yearIFRSnet income increases by 12% (12% in Swiss francs), whilecore earnings per share are up 11%Highlights in the second quarter:EU approvals ofPolivy (first-line treatment for aggressive form of blood cancer),Lunsumio (follic...
Source: Roche Media News - July 21, 2022 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022
Group sales up 5%1 at constant exchange rates (CER) and 5% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for new medicines to treat severe diseases; as expected, the impact of biosimilars slows down furtherDiagnostics Divisionsales grow 11%; ongoing strong base business; demand for COVID-19 tests is expected to decline in the second half of the yearIFRSnet income increases by 12% (12% in Swiss francs), whilecore earnings per share are up 11%Highlights in the second quarter:EU approvals ofPolivy (first-line treatment for aggressive form of blood cancer),Lunsumio (follicular lymphoma) andT...
Source: Roche Investor Update - July 21, 2022 Category: Pharmaceuticals Source Type: news

Pre-op exercises could save the love lives of prostate patients by reducing risk of impotence
A radical prostatectomy involves removing the walnut-sized prostate gland - which is located between the bladder and rectum - in order to clear the cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - July 11, 2022 Category: Consumer Health News Source Type: news

BCG Vaccine Benefit in Non –Muscle Invasive Bladder Cancer? BCG Vaccine Benefit in Non –Muscle Invasive Bladder Cancer?
Among patients with very high-risk but not high-risk disease, bacillus Calmette-Gu érin more effectively delayed time to progression compared with transurethral resection of the bladder.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 5, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASCO 2022: A Reflection on Data to Build On in Bladder Cancer ASCO 2022: A Reflection on Data to Build On in Bladder Cancer
Cheryl Lee, MD, considers the updates on several studies presented at ASCO 2022.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 30, 2022 Category: Consumer Health News Tags: None MDAngle Source Type: news

ASCO 2022: Data for Better Decision-Making in the Treatment of Advanced Bladder Cancer ASCO 2022: Data for Better Decision-Making in the Treatment of Advanced Bladder Cancer
Tracy L. Rose, MD, MPH, discusses the immediate impact that study data from the 2022 ASCO annual meeting bladder cancer poster sessions will have on treatment decisions facing providers and patients.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 27, 2022 Category: Consumer Health News Tags: None MDAngle Source Type: news